Clinical trial
Bone Marrow Transplantation in Treating Children With Sickle Cell Disease
NCT00004485 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00004485 |
|---|---|
| Title | Bone Marrow Transplantation in Treating Children With Sickle Cell Disease |
| Official title | Phase I/II Study of Induction of Stable Mixed Chimerism After Bone Marrow Transplantation From HLA-Identical Donors in Children With Sickle Cell Disease |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Sickle Cell Anemia |
| Intervention type | Drug, Procedure |
| Interventions | cyclosporine, fludarabine, mycophenolate mofetil, Bone Marrow Transplantation |
| Enrollment | 50 |
| Start date | Dec 1, 1999 |
| Primary completion | Aug 1, 2007 |
| First posted | Oct 19, 1999 |
| Last update posted | Sep 10, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: